Coronavirus Vaccine Update From the CDC With Nancy Messonnier
Coronavirus Vaccine Update From the CDC With Nancy Messonnier
Nancy E. Messonnier, MD is Director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the @CDC and leads the CDC’s efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new @jnj vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021.Topics discussed in this interview:
0:00 Introduction
0:36 Variants
2:55 Rapidity of variant emergence
3:55 Staying the course with vaccination
5:52 Speed of vaccine deployment
7:05 Supply of vaccines
8:01 Struggles with distribution
9:20 Incentives for vaccination
12:05 Delaying the second dose
13:44 Vaccination with prior infection
14:52 Stratifying vaccines for different groups
18:09 Vaccination during pregnancy and breastfeeding
20:14 Immunocompromised individuals
22:38 Duration of immunity
23:50 Safety surveillance systems
26:46 Global approach to vaccination
28:28 AstraZeneca and Novavax
29:10 Surprises
30:59 Speed of vaccine development
32:21 Livestream interruption
35:17 Livestream continues
36:23 Booster doses
36:45 Which vaccine the Queen of England got
37:25 Equity and vaccine distribution
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.